Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trialRADIOTHERAPY AND ONCOLOGYIF5.32020-05-0114PREAI
Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort studyRADIOTHERAPY AND ONCOLOGYIF5.32019-06-019PREAI
Late toxicity after single dose HDR-BT and EBRT for prostate cancer: clinical-dosimetric predictorsRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Pattern of Relapse after Metastases Directed Therapy in Patients with Oligorecurrent Prostate Cancer Detected with Choline PET-CTINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52018-11-010OAAI
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52018-08-017PREAI
Utility of Magnetic Resonance imaging in the diagnosis of Radiation osteitis in sarcoma patientsRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Clinical outcomes of HDR-prostate brachytherapy 19Gy single fraction: prospective phase II trialRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trialRADIOTHERAPY AND ONCOLOGYIF5.32018-02-0117PREAI
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52017-10-010PREAI
Efficacy of radiotherapy for painful bone metastases in elderly patientsRADIOTHERAPY AND ONCOLOGYIF5.32017-05-010OAAI
QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy single fraction: phase II trialRADIOTHERAPY AND ONCOLOGYIF5.32017-05-010OAAI
Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed TomographyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52016-10-012OAAI
Prognostic Value of Maximum Standardized Uptake Value Measured by Pretreatment 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinoma: Adding Value to Clinical StagingINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52016-10-010OAAI
Salvage Treatment in Patients With Prostate Cancer Oligorecurrence: Impact of 18-F-Fluorocholine Positron Emission Tomography/Computed Tomography on Clinical Decision MakingINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52016-10-010PREAI
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trialRADIOTHERAPY AND ONCOLOGYIF5.32016-04-0173PREAI
Incidence of Pain Flare Following Palliative Radiation Therapy for Symptomatic Bone Metastases: Multicenter Prospective Observational StudyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52014-09-012PREAI
The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approachCANCER TREATMENT REVIEWSIF10.52014-02-0133PREAI